Afternoon Symposium - MEFS Symposium: Complete Prevention of OHSS—Is It Possible?
Time:3:45 pm - 5:45 pm
Location:HCC316 - Hawaii Convention Center
Botros R.M.B. Rizk, M.D. (Chair), University of South Alabama
William E. Gibbons, M.D., Baylor Family Fertility Program
Needs Assessment and Description
Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of ovarian stimulation resulting in strokes, renal failure, acute respiratory distress syndrome (ARDS), and death. Despite extensive research and study of this condition, every year these serious complications occur in the United States and worldwide. Accurate prediction and prompt prevention could abolish these complications. Management of cerebrovascular thrombosis and fluid management are key issues in reducing morbidity and mortality. This session is for reproductive endocrinologists involved in assisted reproductive technology (ART) and gynecologists with special interest in infertility, as well as fellows in reproductive medicine, radiologists, and ultrasonographers involved in the clinical care of patients suffering from OHSS.
At the conclusion of this presentation, participants should be able to:
- Outline strategies for prediction, prevention, and management of OHSS.
- Present ideal protocols to eliminate OHSS or at least diminish its incidence.
- Discuss the incidence of arterial thrombosis after OHSS and its detection and management.
- Discuss fluid management in severe OHSS.
After participating in this session, in my practice I will promptly start anticoagulant therapy in the following patients after an in vitro fertilization (IVF) cycle:
a. Patients with ovaries that are 5 cm or more in diameter
b. Patients admitted to the hospital with severe ovarian hyperstimulation syndrome (OHSS)
c. Patients with a twin gestation
d. Patients with moderate OHSS
e. Not applicable to my area of practice